Lupin Company Description
Lupin Limited, together with its subsidiaries, operates as a pharmaceutical company in India and internationally.
It engages in the drug discovery, development, production, marketing, and sale of various branded and generic formulations, biosimilars, over-the-counter and specialty drugs, and active pharmaceutical ingredients (APIs).
The company offers formulations for use in the therapeutic areas of anti-tuberculosis, diabetes management, cardiovascular, chronic obstructive pulmonary diseases, asthma, gynecology and women’s health, central nervous system, oncology, immunology, genomics, metabolic disorders, dermatology, urology, pediatrics, gastrointestinal, anti-infective, and nonsteroidal anti-inflammatory drug therapies, as well as engages in the bio clinical research activities.
It operates through network consists of labs, LupiMitra collection centers, and pick-up points. The company was formerly known as Lupin Chemicals Limited and changed its name to Lupin Limited in 2001.
Lupin Limited was founded in 1968 and is headquartered in Mumbai, India.
Country | India |
Founded | 1968 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 19,210 |
CEO | Vinita Gupta |
Contact Details
Address: Kalpataru Inspire Mumbai, Maharashtra 400055 India | |
Phone | 91 22 6640 2323 |
Website | lupin.com |
Stock Details
Ticker Symbol | LUPIN |
Exchange | National Stock Exchange of India |
Fiscal Year | April - March |
Reporting Currency | INR |
ISIN Number | INE326A01037 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Vinita D. Gupta | Chief Executive Officer and Executive Director |
Ramesh Swaminathan | Executive Director, Global Chief Financial Officer, CRO and Head of API Plus SBU |
Nilesh Deshbandhu Gupta | MD and Executive Director |
Christoph Funke | Chief Technical Operations Officer |
Sreeji Gopinathan | Chief Information Officer |
Dr. Shahin Fesharaki | President -Global Chief Scientific Officer |
Ravi Agrawal | Senior Vice President of Investor Relations and M&A |
Dr. Sofia Mumtaz | President of Legal and Compliance of Australia, Japan and Canada Business |
Amit Kumar Gupta | Company Secretary and Compliance Officer |
Rajalakshmi Azariah | Vice President and Global Head of Corporate Communications |